Search results for "Prostate Cancer"
Oral drug for postpartum depression approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/10/oral-drug-for-postpartum-depression-approved.htm
1 Oct 2023
Little difference found among prostate cancer treatments regarding clinical results, patient-reported outcomes
More men in the active-monitoring group developed metastases than in the surgery or radiotherapy groups, and there were higher rates of disease progression in the active-monitoring group than in the surgery or radiotherapy groups.
https://immattersacp.org/weekly/archives/2016/09/20/2.htm
20 Sep 2016
OTC birth control pill, naloxone gain approval
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/09/otc-birth-control-pill-naloxone-gain-approval.htm
1 Sep 2023
More patients undergoing active surveillance for lower-risk prostate cancers
Use of active surveillance or watchful waiting for prostate cancer rose from 2010 to 2018, although uptake was lower in men with multiple positive biopsy cores and those who were Asian/Pacific Islander and Hispanic, had a lower income, or lived in a rural area.
https://immattersacp.org/weekly/archives/2023/04/11/4.htm
11 Apr 2023
Sorting through the science of PSA screening
An expert clears up issues surrounding prostate cancer screening recommendations at Internal Medicine Meeting 2022.
https://immattersacp.org/archives/2022/07/sorting-through-the-science-of-psa-screening.htm
1 Jul 2022
Comorbid illnesses still more likely to kill prostate cancer survivors
Veterans Affairs solicits applications for centers of excellence
https://immattersacp.org/weekly/archives/2010/08/31/6.htm
31 Aug 2010
Guidelines suggest more informed consent for prostate cancer screening
MKSAP Quiz: optimal management of coronary artery disease
https://immattersacp.org/weekly/archives/2010/03/09/2.htm
9 Mar 2010
No mortality benefit associated with primary androgen deprivation therapy in localized prostate cancer
Primary androgen deprivation therapy (PADT) yielded no mortality benefit compared with no PADT in men with clinically localized prostate cancer, according to a new study.
https://immattersacp.org/weekly/archives/2014/03/25/5.htm
25 Mar 2014
New guidance urges caution on testosterone
Internists considering testosterone therapy are ideally positioned to consider a broader differential diagnosis that will actually help the patient.
https://immattersacp.org/archives/2020/05/new-guidance-urges-caution-on-testosterone.htm
1 May 2020
European study finds prostate cancer mortality reduced by PSA screening
Prostate-specific antigen (PSA)-based screening significantly reduced mortality from prostate cancer but did not affect all-cause mortality, according to two more years of follow-up results in the European Randomized Study of Screening for Prostate Cancer.
https://immattersacp.org/weekly/archives/2012/03/20/4.htm
20 Mar 2012